Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 58-74-2
- Molecular formula
- C20H21NO4
- Molecular weight
- 339.4 g/mol
- Drug class
- Benzylisoquinoline alkaloiddirect-acting smooth-muscle relaxant and vasodilator
- Mechanism of action
- The precise mechanism is not completely established. Papaverine appears to inhibit multiple phosphodiesterase isoenzymes, increase intracellular cyclic nucleotide signalling and may also directly inhibit calcium channels, relaxing vascular and visceral smooth muscle.
- Indications / reported uses
- Treatment of selected smooth-muscle spasm or vasospastic conditions with formulations and routes authorised in the relevant jurisdiction.
- Intracavernosal use for erectile dysfunction has been described in specialist practice but should not be interpreted as a universal approved indication.
Sources: https://www.ncbi.nlm.nih.gov/mesh/68010208 · https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride